Company Description
Walgreens Boots Alliance, Inc. operates as a healthcare, pharmacy, and retail company in the United States, Germany, the United Kingdom, and internationally.
The company operates in three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare.
The U.S. Retail Pharmacy segment engages in the operation of retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offer health and wellness, beauty, personal care and consumables, and general merchandise.
The International segment offers the sale of prescription drugs and health and wellness, beauty, personal care, and other consumer products outside the United States; and operates pharmacy-led health and beauty retail businesses under the Boots brand stores in the United Kingdom, the Republic of Ireland, and Thailand, as well as the Benavides brand in Mexico and the Ahumada brand in Chile.
The U.S. Healthcare segment provides VillageMD, a national provider of value-based care with primary, multi-specialty, and urgent care providers serving patients in traditional clinic settings, in patients’ homes and online appointments; Shields, a specialty pharmacy integrator and accelerator for hospitals; and CareCentrix, a participant in the post-acute and home care management sectors.
Walgreens Boots Alliance, Inc. was formerly known as Walgreen Co. and changed its name to Walgreens Boots Alliance, Inc. in December 2014.
Walgreens Boots Alliance, Inc. was founded in 1909 and is based in Deerfield, Illinois.
| Country | United States |
| Founded | 1901 |
| Industry | Pharmaceutical Retailers |
| Sector | Healthcare |
| Employees | 312,000 |
| CEO | Timothy Wentworth |
Contact Details
Address: 108 Wilmot Road Deerfield, Illinois 60015 United States | |
| Phone | 847 315 3700 |
| Website | walgreensbootsalliance.com |
Stock Details
| Ticker Symbol | WBA |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | September - August |
| Reporting Currency | USD |
| CIK Code | 0001618921 |
| CUSIP Number | 931427108 |
| ISIN Number | US9314271084 |
| Employer ID | 47-1758322 |
| SIC Code | 5912 |
Key Executives
| Name | Position |
|---|---|
| Timothy C. Wentworth | Chief Executive Officer and Director |
| Stefano Pessina | Executive Chairman of the Board |
| Manmohan Mahajan | Executive Vice President and Global Chief Financial Officer |
| Ornella Barra | Chief Operating Officer of International |
| Mary Langowski | Executive Vice President and President of Walgreens Health |
| Todd D. Heckman | Senior Vice President, Global Controller and Chief Accounting Officer |
| Matthew D'Ambrosio | Senior Vice President and Global Chief Compliance and Ethics Officer |
| Lanesha T. Minnix J.D. | Executive Vice President and Global Chief Legal Officer, Secretary |
| Elizabeth L. Burger | Executive Vice President and Chief Human Resources Officer |
| Liyue Wu | Head of M&A - Asia |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 28, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 28, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 28, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 28, 2025 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Aug 28, 2025 | POSASR | Filing |
| Aug 28, 2025 | SCHEDULE 13D/A | Filing |
| Aug 28, 2025 | SC 13E3/A | [Amend] Going private transaction by certain issuers |
| Aug 28, 2025 | 8-K | Current Report |
| Aug 28, 2025 | 25-NSE | Filing |
| Aug 15, 2025 | 13F-HR | Quarterly report filed by institutional managers, holdings |